ASX Gainers: Three Stocks Leading the Post-Christmas Rally

3 min read | December 27, 2024 12:36 PM AEDT | By Team Kalkine Media

ASX Gainers: Three Stocks Leading the Post-Christmas Rally — Image source: Miha Creative

Bowen Coking Coal Ltd (ASX:BCB)

Price Surge: 17% increase to 7 cents

Record-Breaking Sales:
Bowen Coking Coal has posted strong results with a 31% increase in coal sales for the quarter, reaching 544Kt. This represents a new quarterly sales record, further demonstrating the company's solid performance.

CEO's Comments:
Daryl Edwards, Bowen’s CEO, expressed pride in the achievement, emphasizing the strong performance of the Burton Mine Complex. “We are proud to report another record being achieved, this time a quarterly coal sales record,” he said.

Investor Takeaway:
This achievement reinforces Bowen’s operational stability and highlights its ability to meet growing demand for coking coal, boosting investor confidence.

DroneShield Ltd (ASX:DRO)

Price Surge: 13% increase to 72.5 cents

Market Rebound:
While no major announcements were made today, DroneShield’s stock is seeing a strong uptick as investors seize the opportunity following its 56% decline over the past six months.

Sector Position:
Specializing in counter-drone technology, DroneShield remains a key player in the defense technology sector, making it an attractive long-term investment option.

Investor Takeaway:
Today’s performance signals a potential rebound as investor sentiment improves, presenting a possible buying opportunity for those looking at future growth.

Mesoblast Ltd (ASX:MSB)

Price Surge: 8% increase to $2.76

Regulatory Milestone:
Mesoblast’s stock rose after announcing that the US FDA has approved its Ryoncil (remestemcel-L) product. This makes it the first mesenchymal stromal cell (MSC) therapy approved in the US for treating steroid-refractory acute graft versus host disease (SR-aGvHD) in children as young as two months old.

Future Outlook:
The approval of Ryoncil marks a significant breakthrough for Mesoblast, with analysts optimistic that this will open doors for other stem cell therapies seeking regulatory approval.

Investor Takeaway:
This milestone significantly boosts Mesoblast’s market credibility and positions the company for further growth in the regenerative medicine sector.

Today’s top ASX performers—Bowen Coking Coal, Mesoblast, and DroneShield—illustrate the variety of drivers behind market movements, from operational success and regulatory breakthroughs to potential rebounds from oversold levels. Investors may want to keep a close eye on these stocks as we approach 2025

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.